Neurolytic Healthcare Analysis: $3M Raised
What is Neurolytic Healthcare?
My Hair UK specializes in hair transplant procedures, offering services in London and Manchester. The clinics utilize Follicular Unit Extraction (FUE) for minimally invasive hair restoration, focusing on natural-looking results. Their surgical team has over 30 years of combined experience in hair transplant surgeries.
Location
158-160 Kenton Rd, Harrow, HA3 8AZ, United Kingdom
Business Model
Subscription-based revenue model charging $279/month for software and services.
Product Features & Capabilities
- genomics-based telehealth services for migraine care, personalized treatment plans, DNA testing services, analysis of genetic markers and biomarkers, ongoing telehealth support
How much Neurolytic Healthcare raised
Seed - $3.2 million
July 27, 2022Lead Investor: Initialized Capital, Y Combinator, and 6 other investors
Who are the founders of Neurolytic Healthcare
RR
IN
Inna Nicole Thalmann
Co-Founder and COO
Investors
- Initialized Capital
- Y Combinator
- Illumina
- Inaki Berenguer (Angel Investor)
- 4 other unnamed investors
Competitors Overview
Neurolytic Healthcare operates in the genomics-based telehealth market, specifically focusing on migraine care. Its main competitor is Mable, which also specializes in personalized migraine treatment using genetic data.
-
Mable:
- Overview: Mable is a telehealth service that utilizes DNA analysis to tailor migraine treatments for patients. It aims to provide personalized medication and continuous expert care.
- Advantages: Mable's approach is centered on integrating genetic insights into treatment plans, which may offer a more customized experience for patients suffering from migraines. This focus on genetics allows for potentially more effective treatment options based on individual genetic profiles.
-
Other Notable Competitors:
- While specific competitors were not detailed in the search results, companies like Trice Medical and Sense Neuro Diagnostics were mentioned as alternatives to Neurolytic Healthcare. These companies may also be involved in telehealth or diagnostics but may not focus exclusively on migraine care or genomics.
In summary, Neurolytic Healthcare's primary competitor, Mable, differentiates itself through its strong emphasis on genetic data in migraine treatment, which could provide a significant advantage in personalizing care for patients.
Market Focus
Neurolytic Healthcare primarily focuses on the health tech industry, specifically in genomics-based telehealth services for migraine care.
See something that needs updating? Suggest edits to this profile.